Rydapt set for EU approval after Novartis addresses CHMP concerns

 
• By Maureen Kenny
  
Targets hit in the center by arrows
Rydapt would be first targeted treatment in the EU for certain AML patients • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography